Breaking News

More PPE for Covid-19 fight

Donations towards Covid-19 continue to pour in as Egypt, the Parliament of Zimbabwe and the business community, ...

Get breaking news alerts.
Don't miss a thing.
Subscribe

COVID-19 liver damage may be more common than previously thought

14 Aug, 2020 - 02:08 0 Views
COVID-19 liver damage may be more common than previously thought

The Herald

James Kingsland

Compared with hospitalized patients in China, a new study finds higher rates of abnormal liver tests among patients receiving treatment in hospitals in the United States. Higher levels of liver enzymes seem to be associated with an increased risk of admission to intensive care and death.

Researchers at the Yale Liver Center in New Haven, CT, analyzed liver tests from 1,827 patients with COVID-19. All were admitted to Yale-New Haven Health hospitals between March 14 and April 23, 2020.

These tests measure levels of enzymes that the liver releases into the bloodstream when it sustains damage.

An analysis of data from China suggests that around 15 percent of hospitalized COVID-19 patients had abnormal liver test results. However, 42–67 percent of the patients in the Yale study had abnormal tests upon admission to the hospital, depending on which of two enzymes the tests measured.

During hospitalization, these figures rose to 62 percent and 83 percent, respectively.

The results appear in the journal Hepatology.

Underlying liver disease

The researchers are unsure why the livers of COVID-19 patients in the US are more likely to have sustained damage, but underlying health differences between Chinese and US populations may be responsible.

“We can speculate that U.S. patients may have an increased rate of other risk factors, such as alcoholic or nonalcoholic fatty liver disease,” says senior study author Dr. Joseph Lim, the director of the Yale Viral Hepatitis Program.

Nonalcoholic fatty liver disease (NAFLD) has links to obesity, high blood pressure, diabetes, and high cholesterol levels.

The National Institutes of Health (NIH) estimate that 30–40 percent of adults in the US have NAFLD. In addition, millions of people have chronic liver infections due to hepatitis B and hepatitis C.

When the researchers looked at the patients’ medical records, they found that around one-quarter of them had abnormal liver tests before contracting SARS-CoV-2.

Regardless of whether they developed liver problems before or after hospitalization with COVID-19, having abnormal test results was associated with worse outcomes from the illness.

After adjusting for other risk factors — including age, sex, body mass index (BMI), and the presence of diabetes — the researchers found that patients with abnormal liver tests were more likely to need intensive care, more likely to require mechanical ventilation, and more likely to die.

The study authors write that this likely reflects direct damage by the virus elsewhere in the body, rather than damage to the liver itself.

Even though liver cells carry the ACE2 receptors that the virus uses to gain entry to cells, the researchers’ analysis suggests that most of the damage is due to inflammation resulting from an infection elsewhere — namely, the bile duct. -Medical News Today

Share This:

Sponsored Links